Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124415652 | 12441565 | 2 | F | 20160528 | 20160811 | 20160607 | 20160818 | EXP | US-UNITED THERAPEUTICS-UNT-2016-008755 | UNITED THERAPEUTICS | 0.00 | A | F | Y | 0.00000 | 20160818 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124415652 | 12441565 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.0405 ?G/KG, CONTINUING | 21272 | INJECTION | |||||||||
| 124415652 | 12441565 | 2 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 7 | C | ADCIRCA | TADALAFIL | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 8 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 9 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 10 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 11 | C | HUMIRA | ADALIMUMAB | 1 | 0 | ||||||||||||
| 124415652 | 12441565 | 12 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124415652 | 12441565 | 1 | Pulmonary arterial hypertension |
| 124415652 | 12441565 | 2 | Product used for unknown indication |
| 124415652 | 12441565 | 3 | Product used for unknown indication |
| 124415652 | 12441565 | 4 | Product used for unknown indication |
| 124415652 | 12441565 | 5 | Product used for unknown indication |
| 124415652 | 12441565 | 6 | Product used for unknown indication |
| 124415652 | 12441565 | 7 | Product used for unknown indication |
| 124415652 | 12441565 | 8 | Product used for unknown indication |
| 124415652 | 12441565 | 9 | Product used for unknown indication |
| 124415652 | 12441565 | 10 | Product used for unknown indication |
| 124415652 | 12441565 | 11 | Product used for unknown indication |
| 124415652 | 12441565 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124415652 | 12441565 | HO |
| 124415652 | 12441565 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124415652 | 12441565 | Death | |
| 124415652 | 12441565 | Hypotension | |
| 124415652 | 12441565 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124415652 | 12441565 | 1 | 20151219 | 0 |